ArticleFrontiers in immunology2025
Exploring the biological functions and immune regulatory roles of IRAK3, TNFRSF1A, CX3CR1, and JUNB in T2DM combined with MAFLD: integrated bioinformatics and single-cell analysis.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Network Toxicology Reveals the Mechanisms of the Plasticizer Metabolite MECPP in Metabolic Diseases.International journal of molecular sciences · 2026Article
- Article
- Identification and preliminary clinical validation of type 2 diabetes signature genes through machine learning analysis of scRNA-seq data.Frontiers in medicine · 2026Article
- Risk Factors for Recurrence in Patients with Hepatocellular Carcinoma After Curative Resection or Ablation.Journal of hepatocellular carcinoma · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Diabetes mellitus combined with nonalcoholic fatty liver disease is a prevalent and intricate metabolic disorder that presents a significant global health challenge, imposing economic and emotional burdens on society and families. An in-depth understanding of the disease pathogenesis is crucial for enhancing diagnostic and therapeutic efficacy. Therefore, the study aims to identify and validate autophagy-related diagnostic biomarkers associated with T2DM-associated MAFLD, investigate regulatory mechanisms in disease progression, and explore cellular diversity within the same tissue using single-cell sequencing data. Methods: This study utilized four datasets retrieved from the Gene Expression Omnibus (GEO) database: GSE15653, GSE89632, GSE24807 and GSE23343. The analysis involved variance analysis, WGCNA analysis, PPI network construction, machine learning application, examination of autophagy-related gene sets, and diagnostic ROC analysis to identify and validate autophagy-related biomarkers in T2DM combined with MAFLD within an independent external dataset. Functional enrichment analysis, immune infiltration analysis, and validation of gene significance in T2DM combined with MAFLD progression were conducted using animal experiments to understand the biological functions and immunomodulatory roles of key biomarkers. Cellular diversity within liver tissues was characterized at the single-cell level, exploring interrelationships, differentiation, and developmental trajectories among cell populations through cellular communication and pseudo-temporal analyses. Results: The study identified four key biomarkers (IRAK3, TNFRSF1A, CX3CR1, JUNB). Real-time fluorescence quantitative PCR analysis in animal experiments demonstrated significantly higher mRNA expression levels of IRAK3, TNFRSF1A, CX3CR1, and JUNB in T2DM and MAFLD rat liver tissues compared to the control group. Quantitative immunohistochemical analysis revealed notably elevated protein expression levels of IRAK3, TNFRSF1A, CX3CR1, and JUNB in liver tissues of rats with T2DM and MAFLD when contrasted with the control group (P < 0.05). Enrichment analysis indicated associations of T2DM combined with MAFLD pathogenesis with pathways such as the NF-kappa B signaling pathway, MAPK signaling pathway, Fluid shear stress and atherosclerosis, Insulin resistance, and Cytokine-cytokine receptor interaction. Correlative analysis uncovered connections between immune infiltration and the identified genes. Single-cell transcriptomic analysis highlighted the differentiation of CX3CR1, JUNB, and TFRC in various single-cell-annotated populations. The pseudo-temporal analysis of epithelial cells identified enriched genes at crucial nodes related to "Leukocyte transendothelial migration", "Lipid and atherosclerosis", and "Type II diabetes mellitus" signaling pathways. Additionally, four cellular communication signaling pathways (TNF, CXCL, VEGF, and MIF) potentially significant in T2DM combined with MAFLD progression were identified through cell communication analysis. Conclusion: This study unveiled potential associations and key biomarkers (IRAK3, TNFRSF1A, CX3CR1, JUNB) concerning T2DM combined with MAFLD and relevant pathways, offering novel insights for the investigation of these two conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.